Sarah Amend

Medicine & Life Sciences

1. Neoplasms 100%
2. Prostatic Neoplasms 67%
3. Extracellular Vesicles 44%
4. Neoplasm Metastasis 42%
5. Ecology 33%
6. Ecosystem 29%
7. Macrophages 28%
8. Circulating Neoplastic Cells 28%
9. Bone and Bones 24%
10. Liquid Biopsy 22%
11. Wetlands 20%
12. Recurrence 17%
13. Lipid Droplets 17%
14. Phenotype 16%
15. POL5551 16%
16. Tumor Microenvironment 16%
17. Cell Cycle Checkpoints 14%
18. Bone Marrow 13%
19. Integrins 13%
20. Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC)) 13%
21. Biomarkers 12%
22. Aneuploidy 12%
23. Dissection 12%
24. Interleukin-4 Receptor alpha Subunit 12%
25. Proteins 11%
26. Drug Therapy 11%
27. Prostate 11%
28. Castration 11%
29. Polyploidy 11%
30. Prostatectomy 11%
31. Kidney Neoplasms 10%
32. Therapeutics 10%
33. Seeds 10%
34. Renal Cell Carcinoma 10%
35. Genome 10%
36. Leukapheresis 10%
37. Thrombospondin 1 9%
38. Single-Cell Analysis 9%
39. Osteoclasts 9%
40. Population 9%
41. Kinesin 9%
42. Quantitative Trait Loci 9%
43. Cell Separation 9%
44. Cell Survival 9%
45. Bone Matrix 8%
46. Triple Negative Breast Neoplasms 8%
47. Technology 8%
48. Messenger RNA 8%
49. Urine 8%
50. Plasma Cells 8%